Episode 39: Will Shrank, Co-Founder & CEO of Aradigm
From Digital Health Heavyweights · 34:45
Show by Norm Volsky
In Episode 39 of Digital Health Heavyweights, Norm Volsky sits down with Will Shrank, CEO and Co-Founder of Aradigm, to explore one of healthcare's biggest emerging challenges: how to make breakthrough cell and gene therapies accessible to patients while keeping costs sustainable for employers, health plans, and the broader healthcare system.With a career spanning medicine, government, health plans, research, investing, and entrepreneurship, Will brings a unique perspective on why healthcare remains so fragmented and what needs to change as medical innovation continues to accelerate.Cell and gene therapies have the potential to fundamentally transform how we treat serious diseases, offering new possibilities for patients who previously had limited options.But these breakthroughs also introduce a major financial challenge.Unlike traditional treatments that spread costs over months or years, some advanced therapies come with enormous upfront expenses, creating unpredictable financial risks for employers and health plans.The question isn't just whether we can develop these treatments. It's whether we can build a healthcare system capable of making them accessible.In this episode, you'll uncover:🧬 Why breakthrough cell and gene therapies are creating new challenges for healthcare affordability and access💰 How high-cost, potentially one-time treatments introduce financial uncertainty for employers and health plans🧩 Why fragmentation continues to limit healthcare's ability to coordinate care and manage costs effectively🤝 How risk pooling and shared accountability could make innovative treatments more financially sustainable🏛️ The potential role of government and public-private partnerships in expanding access to advanced therapies📊 Why measuring the value of medical innovation requires looking beyond upfront costs to long-term outcomes and quality of life🔍 What employers should be asking their healthcare partners about managing high-cost therapies and unpredictable claims⚖️ Why healthcare policy and financing models need to evolve alongside scientific breakthroughs🤖 How AI and advances in manufacturing could influence the future cost and accessibility of innovative treatments🔮 Why the future of healthcare depends on collaboration between purchasers, providers, manufacturers, and other stakeholdersAbout Will Shrank:Will Shrank is the Co-Founder and CEO of Aradigm, where he is focused on addressing the financial and structural challenges associated with bringing breakthrough medical therapies to patients.Throughout his career, Will has worked across multiple areas of the healthcare industry, including clinical medicine, government, health plans, research, investing, and entrepreneurship.His experience across these different parts of the healthcare ecosystem has shaped his perspective on the challenges of fragmentation, the importance of shared accountability, and the need for financing models that can support continued medical innovation.Chapters:00:18 Introduction to Will Shrank and His Work at Aradigm01:31 Will's Career Journey Across the Healthcare Industry02:14 Why Healthcare Remains So Fragmented03:12 Lessons from Healthcare Reform and Value-Based Care06:09 Bridging the Gap Between Medical Innovation and Patient Access08:20 Why Will Co-Founded Aradigm09:19 The Financial Challenge of Cell and Gene Therapies11:36 Pooling Risk and Building Coordinated Healthcare Partnerships14:03 Managing Unpredictable, High-Cost Healthcare Claims16:27 The Government's Potential Role in Expanding Treatment Access18:39 What Employers Should Be Asking About High-Cost Therapies21:17 Measuring Long-Term Value Beyond Upfront Treatment Costs25:25 Keeping Healthcare Policy Aligned with Medical Innovation26:37 How AI and Manufacturing Advances Could Influence Therapy Costs29:04 Challenging the Perception That Healthcare Innovation Is Slow30:01 What Healthcare Leaders Need to Do Differently30:57 Entrepreneurship, Managing Stress, and Playing Tennis32:39 Healthy Cooking and Everyday Wellness Habits34:12 Closing ThoughtsFollow, connect and subscribe:LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcastYoutube: https://youtube.com/@DigitalHealthHeavyweightsInstagram: https://www.instagram.com/digitalhealthheavyweights/TikTok: https://www.tiktok.com/@heavyweightspodcast
More episodes of Digital Health Heavyweights
More episodes
- Episode 38: Jonathan Hunt-Glassman, Co-Founder and CEO of Oar Health
- Episode 37: Andrew Scott, Senior Director of Health, Equity, and Wellbeing at Willis Towers Watson
- Episode 36: Chip Nash, Co-Founder and CEO of Crux
- Episode 35: Dr. Danny Seidman, Founder of DHS Advisors and Co-Founder of Kin Health
- Episode 34: Matt Harmon, Employee Benefits Consultant at Higginbotham
- Episode 33: Darrell Moon, CEO of Aspirational Healthcare
- Episode 32: Ali Diab, CEO & Co-Founder of Collective Health
- Episode 1 - Michael Laquere, Employer Health Innovation Roundtable (EHIR)
- Episode 2 - Kimon Angelides, Founder of Livongo (Formerly EosHealth) Sold to Teladoc for $18.5 billion
- Episode 3 - Emily Hanson, Director of Platform at SemperVirens Venture Capital
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.